Tomohisa Takaba
Kitakyushu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.
Journal: In vivo (Athens, Greece)
Published: March 19, 2025
Early Experience With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 15, 2025
Survival and Safety Outcomes of Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma from a Single-Center Experience.
Journal: In vivo (Athens, Greece)
Published: February 15, 2025
Clinical significance of the dose modification of enfortumab vedotin monotherapy for advanced urothelial carcinoma.
Journal: Japanese journal of clinical oncology
Published: December 15, 2024
Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
Journal: In vivo (Athens, Greece)
Published: March 20, 2024
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology.
Journal: In vivo (Athens, Greece)
Published: October 15, 2023
IMPACT OF ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 01, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026